Concepedia

Cameron Callaghan

CC

Statistics

Publications

4

Citations

156

H-Index

4

Active since

2015

Affiliations

Tulane University(Current)

University of New Orleans

Cameron Callaghan is an author at Tulane University specializing in renal cell carcinoma, oncology, and pharmacology.

ORCID

Publications per year

2015–2019

4

Publications

4

Comparison of Sorafenib-Loaded Poly (Lactic/Glycolic) Acid and DPPC Liposome Nanoparticles in the in Vitro Treatment of Renal Cell Carcinoma

James H. Liu, Benjawan Boonkaew, Jaspreet Arora et al. · Journal of Pharmaceutical Sciences · 2015 · 64 citations

, , +17

Brachytherapy Future Directions

J. Adam M. Cunha, Ryan T. Flynn, Cédric Bélanger et al. · Seminars in Radiation Oncology · 2019 · 43 citations

Nanotechnology combined therapy: tyrosine kinase‐bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model

James T. Liu, Caleb Abshire, Connor Carry et al. · British Journal of Urology · 2016 · 27 citations

, , +17

Combined Treatment of Tyrosine Kinase Inhibitor–Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model

Cameron Callaghan, Donna V. Peralta, James T. Liu et al. · Journal of Pharmaceutical Sciences · 2016 · 22 citations

, , +14

1–4 of 4